Welcome to our dedicated page for TransUnion SEC filings (Ticker: TRU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The TransUnion (NYSE: TRU) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents offer detailed information on TransUnion’s financial performance, governance and significant corporate events, complementing its role as a global information and insights company and major U.S. credit bureau.
Investors can review current reports on Form 8-K, where TransUnion reports material events such as quarterly earnings announcements and board changes. For example, the company has used 8-K filings to furnish press releases on results for specific quarters and to disclose the appointment of new directors and committee assignments. Such filings help readers understand how TransUnion’s leadership and reporting practices evolve over time.
In addition to 8-Ks, users typically look to annual reports on Form 10-K and quarterly reports on Form 10-Q for comprehensive discussions of business segments, risk factors, credit and fraud solution portfolios, and geographic footprint. These filings explain how TransUnion’s core credit bureau activities, fraud and identity solutions, marketing datasets and analytics offerings contribute to its overall business.
The Stock Titan platform enhances this information by providing AI-powered summaries that highlight key points from lengthy filings, helping readers navigate complex disclosures more efficiently. Real-time updates from the SEC’s EDGAR system ensure that new TransUnion filings appear promptly, while dedicated sections for insider transaction reports on Form 4 and proxy materials give additional insight into executive and director activity and governance matters.
Together, these resources allow investors, analysts and other stakeholders to examine TransUnion’s regulatory history, financial reporting and material events in a structured, accessible format.
TransUnion executive Todd C. Skinner, President, International, reported a small automatic stock sale. On 02/02/2026, he sold 500 shares of TransUnion common stock at a price of $78.79 per share under a pre-arranged Rule 10b5-1 trading plan. After this transaction, he beneficially owned 31,724.727 shares directly.
Todd Skinner has filed a notice of proposed sale of TRU stock under Rule 144. The filing covers 500 shares of common stock to be sold through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $39,395 and 194,200,000 shares outstanding. The approximate sale date is February 2, 2026. The 500 shares come from an employee stock purchase on June 30, 2025 (114 shares bought for cash) and 386 restricted shares that vested on August 25, 2025 as compensation. In the past three months, Skinner sold 500 shares on December 10, 2025 for $40,535 and another 500 shares on January 2, 2026 for $42,855.
Massachusetts Financial Services Company reports beneficial ownership of 15,540,471 shares of TransUnion common stock, representing 8.0% of the outstanding class as of the relevant date. MFS has sole voting power over 15,170,635 shares and sole dispositive power over 15,540,471 shares.
MFS states the shares were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of TransUnion or participating in any control-related transactions.
TransUnion director Charlotte Yarkoni reported a new equity award. On January 5, 2026, she received a grant of 836 shares of TransUnion common stock at a price of $0 per share. This reflects a restricted stock award tied to her service on the Board of Directors.
The 836 restricted shares will vest on May 7, 2026, meaning they become fully owned by her on that date if the vesting conditions are met. Following this grant, she beneficially owns 836 TransUnion shares directly.
TransUnion director Sayan Chakraborty reported an equity award of company stock. On January 5, 2026, he received a grant of 836 shares of common stock, reported at a price of $0 per share, reflecting a restricted stock award rather than an open-market purchase. According to the footnote, these restricted shares were granted in connection with his appointment to the Board of Directors and are scheduled to vest on May 7, 2026. Following this grant, he beneficially owns 836 TransUnion shares, held directly.
TransUnion director files initial ownership report with no holdings
TransUnion director Charlotte Yarkoni filed an initial ownership report covering an event date of 01/05/2026. The filing shows she serves as a director of TransUnion but does not beneficially own any TransUnion securities, as it explicitly states that no securities are beneficially owned.
TransUnion director reports no beneficial ownership on Form 3
TransUnion director Sayan Chakraborty filed an initial ownership report stating that no TransUnion securities are beneficially owned. The filing confirms Chakraborty’s role as a director and indicates that there are no non-derivative or derivative securities reported as directly or indirectly held. This is an administrative disclosure required for insiders and does not describe any stock transactions or option grants.
TransUnion's President, International reported a small insider stock sale under a pre-arranged Rule 10b5-1 trading plan. On 01/02/2026, the officer sold 500 shares of TransUnion common stock at a price of $85.71 per share. After this transaction, the officer beneficially owns 32,224.727 shares of common stock. This ownership amount includes 72.708 shares acquired through the company’s employee stock purchase plan since the officer’s prior report.
TransUnion reported an insider stock sale by a senior officer. On 01/02/2026, an officer serving as President, US Markets sold 1,000 shares of TransUnion common stock at a price of $85.71 per share in an open market transaction.
The filing states that this sale was made under a pre-arranged Rule 10b5-1 trading plan, which is designed to allow insiders to trade shares according to a set schedule. After this transaction, the officer beneficially owned 61,592 shares of TransUnion common stock.
A shareholder of TransUnion filed a notice to sell 500 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $42,855.00. The shares to be sold come from 413 shares acquired through restricted stock vesting on 02/25/2025 as compensation and 87 shares purchased under an employee stock purchase plan on 06/30/2025 for cash. Over the prior three months, the same shareholder, Todd Skinner, sold 500 common shares on 12/10/2025 for gross proceeds of $40,535.00. By signing the notice, the shareholder represents that he is not aware of any undisclosed material adverse information about TransUnion.